デフォルト表紙
市場調査レポート
商品コード
1784018

ポイント・オブ・ケア血糖測定の世界市場

Point-of-Care Glucose Testing

出版日
ページ情報
英文 201 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.03円
代理店手数料はかかりません
ポイント・オブ・ケア血糖測定の世界市場
出版日: 2025年08月05日
発行: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
ページ情報: 英文 201 Pages
納期: 即日から翌営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

ポイント・オブ・ケア血糖測定の世界市場は2030年までに41億米ドルに達する見込み

2024年に34億米ドルと推定されるポイント・オブ・ケア血糖測定の世界市場は、2024年から2030年にかけてCAGR 3.3％で成長し、2030年には41億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるAccu Check Aviva Meterは、CAGR 4.1%を記録し、分析期間終了時には11億米ドルに達すると予測されます。Onetouch Verio Flexセグメントの成長率は、分析期間中CAGR 3.6%と推定されます。

米国市場は9億1,650万米ドルと推定、中国はCAGR6.4％で成長予測

米国のポイント・オブ・ケア血糖測定市場は、2024年に9億1,650万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに8億1,940万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは6.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.3％と2.5％と予測されています。欧州では、ドイツがCAGR 1.9%で成長すると予測されています。

世界のポイント・オブ・ケア血糖測定市場- 主要動向と促進要因のまとめ

なぜポイント・オブ・ケア血糖測定が糖尿病管理に不可欠なのか？

ポイントオブケア（PoC）グルコース検査は、糖尿病管理、救急医療、クリティカルケアの現場で重要な役割を果たし、医療従事者や患者がリアルタイムで治療方針を決定できる血糖値を即座に測定します。サンプルの処理時間を必要とする従来の検査室ベースのグルコース検査とは異なり、PoCグルコースメーターは、病院、診療所、外来環境、さらには家庭環境において、その場で迅速なグルコースモニタリングを可能にします。

糖尿病有病率の世界の上昇は、PoCグルコース検査の採用を促進する主な要因の一つです。国際糖尿病連合（IDF）によると、世界中で5億3,700万人以上の成人が糖尿病を患っており、この数は今後数年で大幅に増加すると予想されています。効果的なグルコースモニタリングと血糖コントロールは、低血糖、ケトアシドーシス、心血管疾患などの合併症を予防する上で極めて重要であり、PoCグルコース検査は日常的な糖尿病治療の不可欠な一部となっています。

自己血糖測定（SMBG）装置や持続グルコースモニタリング（CGM）システムの採用が増加しているため、糖尿病患者はグルコースレベルを頻繁に追跡し、それに応じてライフスタイルや投薬の調整を行うことができます。さらに、病院や救急部は、低血糖や高血糖の迅速な検出のためにPoCグルコースメーターに依存しており、即時の治療介入と患者の転帰の改善を確実にしています。

技術の進歩はどのようにPoCグルコース検査を改善しているか？

PoCグルコース検査市場は、バイオセンサー技術、接続ソリューション、非侵襲的グルコースモニタリング技術の進歩により急速に進化しています。

最も重要な技術革新の一つは、無線接続とデジタルヘルスソリューションの統合です。最新のPoCグルコースメーターはBluetooth、Wi-Fi、モバイルアプリの互換性を備え、電子カルテ（EHR）、クラウドベースのプラットフォーム、糖尿病管理アプリケーションへのシームレスなデータ転送を可能にしています。この機能により、遠隔患者モニタリング（RPM）や医師と患者の共同作業が可能になり、糖尿病管理がより積極的かつ効率的になります。

もうひとつの画期的な進歩は、非侵襲的で低侵襲な血糖モニタリング装置の開発です。従来の血糖値測定は指を刺す必要があり、患者にとって苦痛で不便なものでした。企業は現在、ウェアラブル・バイオセンサー、汗を利用したグルコース検出、赤外線を利用して皮膚からグルコースレベルを測定する光学式グルコースセンサーを利用した、針を使わないグルコースモニタリングに注目しています。非侵襲的グルコース検査は、患者のアドヒアランスを向上させ、ユーザーエクスペリエンスを改善することで、糖尿病管理に革命をもたらすと期待されています。

持続グルコースモニタリング（CGM）システムの進歩も市場を再形成しています。1回限りの測定値を提供する従来のPoCグルコース測定器とは異なり、CGMはトレンド分析と低血糖または高血糖のアラートを備えたリアルタイムのグルコースモニタリングを提供します。Abbott（FreeStyle Libre）、Dexcom（G6およびG7）、Medtronic（Guardian Connect）などの主要メーカーは、センサーの装着時間の延長、精度の向上、インスリンポンプとの統合を提供するため、CGM技術を継続的に改善しています。

さらに、AI主導のグルコース分析と予測アルゴリズムは、グルコースモニタリングの精度を高めています。機械学習モデルは現在、グルコースの動向を分析し、変動を予測し、インスリン投与、食事計画、身体活動の調整についてパーソナライズされた推奨を提供することができます。AIを活用したPoCグルコース検査ソリューションは、合併症を減らし、血糖コントロールを改善し、個別化された糖尿病管理をサポートすると期待されています。

PoCグルコース検査の需要がヘルスケアや在宅ケアの現場で高まっているのはなぜか？

糖尿病、代謝異常、生活習慣病の有病率の増加により、病院、外来診療所、在宅介護の現場でPoCグルコース検査が広く採用されています。

  • 病院とクリティカルケアでの使用：ヘルスケア施設では、集中治療室（ICU）、救急治療室（ER）、周術期治療における急性血糖イベントの迅速な診断と管理にPoCグルコース検査を活用しています。手術、外傷治療、化学療法を受ける患者は血糖値が変動することが多く、合併症を予防するためにベッドサイドでの頻繁なグルコースモニタリングが必要となります。
  • セルフモニタリングとホームケア：糖尿病を自宅で管理する人が増えるにつれ、自己血糖測定（SMBG）装置の需要が急増しています。見やすいディスプレイ、音声アシスト機能、クラウドベースの追跡機能を備えたコンパクトで使いやすい血糖測定器は、特に高齢者や視覚障害のある患者にとって、家庭での血糖測定をより便利なものにしています。
  • 妊娠糖尿病モニタリング：妊娠糖尿病（GDM）と診断された妊婦は、母親と赤ちゃんの合併症を予防するために、頻繁なグルコースモニタリングが必要です。GDMの早期発見と管理をサポートするため、妊産婦ケアにおけるポータブル、使い捨て、ワイヤレスのグルコースメーターの採用が増加しています。
  • スポーツ＆フィットネス・アプリケーション：アスリートやフィットネス愛好家は、運動前後のグルコース変動を監視するためにPoCグルコース検査やCGMを使用しています。この動向は、代謝の健康状態やエネルギーの最適化に関する洞察をリアルタイムで提供するウェアラブル・グルコース・モニターの需要を促進しています。

遠隔医療とデジタルヘルスプラットフォームの拡大も、PoCグルコース検査ソリューションの需要拡大に寄与しています。多くの遠隔医療プロバイダーは現在、グルコース・モニタリング・データをバーチャル診察と統合し、高リスク患者の遠隔糖尿病管理と早期介入を可能にしています。

PoCグルコース検査市場の成長を促進する要因は何か？

PoCグルコース検査市場の成長は、技術の進歩、糖尿病有病率の増加、積極的ヘルスケアに対する消費者の意識の高まりによってもたらされます。

  • 糖尿病有病率の上昇と慢性疾患負担の増加：世界の糖尿病の流行は、リアルタイム・グルコース・モニタリング・ソリューションの需要を引き続き促進しています。特にアジア太平洋、ラテンアメリカ、アフリカなどの新興諸国では糖尿病患者が急増しており、各国政府はPoCグルコース検査を組み込んだ全国的な糖尿病スクリーニングおよび予防プログラムの実施を促しています。
  • 糖尿病管理に対する政府および保険による支援：多くの国がグルコースモニタリングデバイスの保険適用と償還政策を拡大しており、PoCグルコースメーターとCGMが糖尿病患者にとってより利用しやすくなっています。FDA、EMA、WHOなどのヘルスケア機関は、医療成果を向上させるため、コネクテッド・グルコースメーターやAI主導の糖尿病管理ツールの使用を推進しています。
  • ウェアラブル＆スマート・グルコース・モニタリング・デバイスの採用増加：従来のグルコースメーターからスマートCGMやバイオセンサーへの移行は、糖尿病治療を再形成しています。特に1型糖尿病患者やインスリン依存の2型糖尿病患者の間で、自動インスリン投与機能を統合したウェアラブルCGMの需要が高まっています。
  • 低侵襲で痛みの少ない検査方法に対する需要の高まり：非侵襲的なグルコースモニタリングソリューションは、患者がより痛みの少ない、便利で継続的なグルコース追跡オプションを求めるにつれて、牽引力を増すと予想されます。涙、汗、唾液ベースのグルコース検出に関する調査が活発化しており、企業は次世代の非侵襲性グルコースセンサーに投資しています。
  • 糖尿病ケアにおけるAIとデータ分析の台頭：AIを活用した予測分析、グルコース傾向予測、パーソナライズされた糖尿病コーチングは、患者とヘルスケアプロバイダーの血糖値管理方法を変革しつつあります。PoCグルコース検査機器に機械学習アルゴリズムを統合することで、治療の意思決定を最適化し、糖尿病関連の合併症を減らすことが期待されます。

グルコースモニタリング技術における継続的な技術革新、遠隔患者モニタリングの採用拡大、ヘルスケアと家庭環境におけるアプリケーションの拡大により、PoCグルコース検査市場は飛躍的な成長を遂げます。コネクテッド・ヘルス・ソリューション、AI主導の診断、患者中心の糖尿病管理戦略が進化するにつれて、PoCグルコース検査は世界中で個別化されたデータ主導型ヘルスケアの要であり続けると思われます。

セグメント

製品（Accu Check Aviva Meter、Onetouch Verio Flex、i-STAT、Bayer Contour Blood Glucose Monitoring System、Freestyle Lite、True Metrix、Accu-Chek Inform II、StatStrip、その他）

調査対象企業の例

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • Bayer AG
  • Dexcom Inc.
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd.
  • iHealth Labs Inc.
  • Insulet Corporation
  • LifeScan Inc.
  • Medtronic plc
  • Nipro Corporation
  • Nova Biomedical
  • Prodigy Diabetes Care, LLC
  • PTS Diagnostics
  • Sanofi S.A.
  • Terumo Corporation
  • Trividia Health, Inc.
  • Ypsomed Holding AG

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMをクエリする代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP32612

Global Point-of-Care Glucose Testing Market to Reach US$4.1 Billion by 2030

The global market for Point-of-Care Glucose Testing estimated at US$3.4 Billion in the year 2024, is expected to reach US$4.1 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Accu Check Aviva Meter, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Onetouch Verio Flex segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$916.5 Million While China is Forecast to Grow at 6.4% CAGR

The Point-of-Care Glucose Testing market in the U.S. is estimated at US$916.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$819.4 Million by the year 2030 trailing a CAGR of 6.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Point-of-Care Glucose Testing Market - Key Trends & Drivers Summarized

Why Is Point-of-Care Glucose Testing Essential in Diabetes Management?

Point-of-care (PoC) glucose testing plays a crucial role in diabetes management, emergency care, and critical care settings, providing immediate blood glucose readings that enable healthcare providers and patients to make real-time treatment decisions. Unlike traditional laboratory-based glucose tests, which require sample processing time, PoC glucose meters allow for rapid, on-the-spot glucose monitoring in hospitals, clinics, ambulatory settings, and even home environments.

The global rise in diabetes prevalence is one of the major factors driving the adoption of PoC glucose testing. According to the International Diabetes Federation (IDF), over 537 million adults worldwide have diabetes, and this number is expected to grow significantly in the coming years. Effective glucose monitoring and glycemic control are critical in preventing complications such as hypoglycemia, ketoacidosis, and cardiovascular diseases, making PoC glucose testing an integral part of routine diabetes care.

The increasing adoption of self-monitoring blood glucose (SMBG) devices and continuous glucose monitoring (CGM) systems has empowered diabetic patients to track their glucose levels frequently and make lifestyle or medication adjustments accordingly. Additionally, hospitals and emergency departments rely on PoC glucose meters for rapid hypoglycemia and hyperglycemia detection, ensuring immediate therapeutic interventions and improved patient outcomes.

How Are Technological Advancements Improving PoC Glucose Testing?

The PoC glucose testing market is rapidly evolving with advancements in biosensor technology, connectivity solutions, and non-invasive glucose monitoring techniques.

One of the most significant innovations is the integration of wireless connectivity and digital health solutions. Modern PoC glucose meters are now equipped with Bluetooth, Wi-Fi, and mobile app compatibility, allowing seamless data transmission to electronic health records (EHRs), cloud-based platforms, and diabetes management applications. This feature enables remote patient monitoring (RPM) and physician-patient collaboration, making diabetes management more proactive and efficient.

Another breakthrough is the development of non-invasive and minimally invasive glucose monitoring devices. Traditional blood glucose testing requires finger-pricking, which can be painful and inconvenient for patients. Companies are now focusing on needle-free glucose monitoring using wearable biosensors, sweat-based glucose detection, and optical glucose sensors that utilize infrared light to measure glucose levels through the skin. Non-invasive glucose testing is expected to revolutionize diabetes management by enhancing patient adherence and improving user experience.

Advancements in continuous glucose monitoring (CGM) systems are also reshaping the market. Unlike traditional PoC glucose meters that provide single-time readings, CGMs offer real-time glucose monitoring with trend analysis and alerts for hypoglycemia or hyperglycemia. Leading manufacturers, such as Abbott (FreeStyle Libre), Dexcom (G6 and G7), and Medtronic (Guardian Connect), are continuously improving CGM technology to offer longer sensor wear, improved accuracy, and integration with insulin pumps.

Additionally, AI-driven glucose analytics and predictive algorithms are enhancing the precision of glucose monitoring. Machine learning models can now analyze glucose trends, predict fluctuations, and provide personalized recommendations for insulin dosing, meal planning, and physical activity adjustments. AI-powered PoC glucose testing solutions are expected to reduce complications, improve glycemic control, and support personalized diabetes management.

Why Is Demand for PoC Glucose Testing Growing Across Healthcare and Homecare Settings?

The increasing prevalence of diabetes, metabolic disorders, and lifestyle-related diseases has led to the widespread adoption of PoC glucose testing in hospitals, outpatient clinics, and homecare settings.

  • Hospital & Critical Care Use: Healthcare facilities utilize PoC glucose testing for rapid diagnosis and management of acute glycemic events in intensive care units (ICUs), emergency rooms (ERs), and perioperative care. Patients undergoing surgery, trauma care, or chemotherapy often experience fluctuations in blood glucose levels, necessitating frequent bedside glucose monitoring to prevent complications.
  • Self-Monitoring & Homecare: The demand for self-monitoring blood glucose (SMBG) devices has surged as more individuals manage diabetes independently at home. Compact, user-friendly glucose meters with easy-to-read displays, voice-assisted functions, and cloud-based tracking have made home-based glucose monitoring more convenient, particularly for elderly and visually impaired patients.
  • Gestational Diabetes Monitoring: Pregnant women diagnosed with gestational diabetes mellitus (GDM) require frequent glucose monitoring to prevent complications for both the mother and baby. The adoption of portable, disposable, and wireless glucose meters in prenatal care is increasing to support early detection and management of GDM.
  • Sports & Fitness Applications: Athletes and fitness enthusiasts are using PoC glucose testing and CGMs to monitor glucose variations before and after workouts. This trend has fueled demand for wearable glucose monitors that provide real-time insights into metabolic health and energy optimization.

The expansion of telemedicine and digital health platforms has also contributed to the growing demand for PoC glucose testing solutions. Many telehealth providers now integrate glucose monitoring data with virtual consultations, enabling remote diabetes management and early intervention for high-risk patients.

What Factors Are Driving the Growth of the PoC Glucose Testing Market?

The growth in the PoC glucose testing market is driven by technological advancements, increasing diabetes prevalence, and rising consumer awareness about proactive healthcare.

  • Rising Diabetes Prevalence & Chronic Disease Burden: The global diabetes epidemic continues to fuel demand for real-time glucose monitoring solutions. Developing countries, particularly in Asia-Pacific, Latin America, and Africa, are experiencing a surge in diabetes cases, prompting governments to implement nationwide diabetes screening and prevention programs that incorporate PoC glucose testing.
  • Government & Insurance Support for Diabetes Management: Many countries are expanding insurance coverage and reimbursement policies for glucose monitoring devices, making PoC glucose meters and CGMs more accessible to diabetic patients. Health agencies such as the FDA, EMA, and WHO are promoting the use of connected glucose meters and AI-driven diabetes management tools to improve healthcare outcomes.
  • Increased Adoption of Wearable & Smart Glucose Monitoring Devices: The transition from traditional glucose meters to smart CGMs and biosensors is reshaping diabetes care. The demand for wearable CGMs with automated insulin delivery integration is growing, particularly among Type 1 and insulin-dependent Type 2 diabetic patients.
  • Growing Demand for Minimally Invasive & Painless Testing Methods: Non-invasive glucose monitoring solutions are expected to gain traction as patients seek less painful, convenient, and continuous glucose tracking options. Research into tear, sweat, and saliva-based glucose detection is gaining momentum, with companies investing in next-generation non-invasive glucose sensors.
  • Rise of AI & Data Analytics in Diabetes Care: AI-driven predictive analytics, glucose trend forecasting, and personalized diabetes coaching are transforming how patients and healthcare providers manage blood sugar levels. The integration of machine learning algorithms into PoC glucose testing devices is expected to optimize treatment decisions and reduce diabetes-related complications.

With continuous innovations in glucose monitoring technology, increasing adoption of remote patient monitoring, and expanding applications in healthcare and home settings, the PoC glucose testing market is set for exponential growth. As connected health solutions, AI-driven diagnostics, and patient-centered diabetes management strategies evolve, PoC glucose testing will remain a cornerstone of personalized, data-driven healthcare worldwide.

SCOPE OF STUDY:

The report analyzes the Point-of-Care Glucose Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • Bayer AG
  • Dexcom Inc.
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd.
  • iHealth Labs Inc.
  • Insulet Corporation
  • LifeScan Inc.
  • Medtronic plc
  • Nipro Corporation
  • Nova Biomedical
  • Prodigy Diabetes Care, LLC
  • PTS Diagnostics
  • Sanofi S.A.
  • Terumo Corporation
  • Trividia Health, Inc.
  • Ypsomed Holding AG

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Point-of-Care Glucose Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Global Diabetes Epidemic and Focus on Glycemic Control Propel Demand for Rapid Point-of-Care Glucose Testing
    • Increased Use of POC Glucose Testing in Emergency Rooms and Acute Care Drives Market Expansion
    • Adoption of Bedside Glucose Monitoring in ICUs and Surgical Wards Enhances Patient Safety and Protocol Compliance
    • Home-Based Diabetes Management and Self-Monitoring Support Widespread Use of Compact POC Glucose Devices
    • Technological Innovation in Continuous and Intermittent Glucose Monitoring Blurs Lines With Traditional POC Devices
    • Integration of POC Glucose Test Results With EHR and Mobile Apps Enables Holistic Chronic Disease Management
    • Public Health Campaigns on Early Diabetes Screening Encourage Testing at Pharmacies and Primary Care Clinics
    • Demand for Rapid Testing in Low-Resource and Rural Areas Supports Use of Portable, Battery-Operated Devices
    • Advancements in Non-Invasive and Painless Glucose Testing Technologies Create Disruption Potential
    • Stricter Infection Control and Cross-Contamination Concerns Support Shift to Single-Use, Disposable Strips
    • Reimbursement Policies for POC Glucose Testing Drive Institutional Adoption Across Outpatient Settings
    • Retail Clinics and DTC Health Providers Expand Glucose Testing Accessibility Beyond Traditional Healthcare Facilities
    • Wearable and Smart Glucose Monitors Integrated With POC Capabilities Gain Traction Among Tech-Savvy Patients
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Point-of-Care Glucose Testing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Point-of-Care Glucose Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Point-of-Care Glucose Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Accu Check Aviva Meter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Accu Check Aviva Meter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Accu Check Aviva Meter by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Onetouch Verio Flex by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Onetouch Verio Flex by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Onetouch Verio Flex by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for i-STAT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for i-STAT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for i-STAT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Bayer Contour Blood Glucose Monitoring System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Bayer Contour Blood Glucose Monitoring System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Bayer Contour Blood Glucose Monitoring System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Freestyle Lite by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Freestyle Lite by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Freestyle Lite by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for True Metrix by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for True Metrix by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for True Metrix by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Accu-Chek Inform II by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Accu-Chek Inform II by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Accu-Chek Inform II by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for StatStrip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for StatStrip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for StatStrip by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • JAPAN
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • CHINA
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • EUROPE
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Point-of-Care Glucose Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Point-of-Care Glucose Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • FRANCE
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: France 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • GERMANY
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 53: Germany Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Germany Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Germany 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 56: Italy Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Italy Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Italy 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 59: UK Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: UK Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: UK 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 62: Spain Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Spain Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Spain 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 65: Russia Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Russia Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Russia 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 68: Rest of Europe Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Europe Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Europe 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 71: Asia-Pacific Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 72: Asia-Pacific Historic Review for Point-of-Care Glucose Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Asia-Pacific 15-Year Perspective for Point-of-Care Glucose Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 74: Asia-Pacific Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Asia-Pacific Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Asia-Pacific 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 77: Australia Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Australia Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Australia 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • INDIA
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 80: India Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: India Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: India 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 83: South Korea Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: South Korea Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: South Korea 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 86: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Asia-Pacific Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Asia-Pacific 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 89: Latin America Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 90: Latin America Historic Review for Point-of-Care Glucose Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Latin America 15-Year Perspective for Point-of-Care Glucose Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 92: Latin America Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Latin America Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Latin America 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 95: Argentina Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Argentina Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Argentina 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 98: Brazil Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Brazil Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Brazil 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 101: Mexico Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Mexico Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Mexico 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 104: Rest of Latin America Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Latin America Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Latin America 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 107: Middle East Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 108: Middle East Historic Review for Point-of-Care Glucose Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Middle East 15-Year Perspective for Point-of-Care Glucose Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 110: Middle East Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Middle East Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Middle East 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 113: Iran Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Iran Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Iran 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 116: Israel Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Israel Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Israel 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 119: Saudi Arabia Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Saudi Arabia Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Saudi Arabia 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 122: UAE Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UAE Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UAE 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 125: Rest of Middle East Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Middle East Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Middle East 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • AFRICA
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 128: Africa Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Africa Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Africa 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030

IV. COMPETITION